Background: Cervical cancer screening programs are facing a programmatic shift where
screening protocol based on human papillomavirus testing (HPV-Screening protocol) is …

Background Human papillomavirus (HPV) testing is increasingly used as the primary
cervical cancer screening test. In a large pilot implementation, we compared participation …

Human papillomavirus (HPV) DNA testing can be used to identify women at risk of the
development of cervical cancer. The cost‐effectiveness of HPV screening is dependent on …

Objectives To compare the short-term and long-term effectiveness of human papillomavirus
(HPV) tests in Norwegian Cervical Cancer Screening Programme (NCCSP). Design …

Introduction Human papillomavirus (HPV) testing as the primary cervical cancer screening
method is implemented in several countries. We report data from the first round of a large …

Studies have shown, that HPV-based screening is more sensitive than cytology-based
screening, but local factors will influence the performance. From January 2021 phased …

Abstract Introduction In Denmark, where human papillomavirus (HPV)‐based cervical
cancer screening is being implemented, the aim of this pilot implementation study was to test …

Background Clinical trials in the research setting have demonstrated that primary human
papillomavirus (HPV)-based screening results in greater protection against cervical cancer …

Abstract Background An Organised Cervical Cancer Screening Programme (OCCSP) was
started in Poland in 2006/2007. Each woman aged 25 to 59 is eligible for a free Pap test …

Background Cytology-based screening has been a cornerstone of cervical cancer
prevention for decades. Following extensive evidence demonstrating higher sensitivity and …